Johnson & Johnson made a tough call recently. They stopped a mid-stage trial for a new eczema drug. The drug, JNJ-5939, was supposed to help people with moderate to severe eczema. But it didn't work as well as hoped. The trial showed that the drug was safe to use. People didn't have bad reactions t
Johnson Matthey, a big name in the chemical industry, has some big changes happening at the top. Richard Pike, who was the finance chief, is now the new Chief Operating Officer. This means he will be in charge of making sure the company runs smoothly every day. At the same time, Alastair Judge, who
Marques Brownlee, the famous tech reviewer, has been in the news lately. Not for his usual tech reviews, but for his wallpaper app, Panels. The app faced backlash for its price and privacy issues. Brownlee listened and is making changes. He's introducing a new subscription tier for just $2 a month.
